Literature DB >> 9459446

Abnormal heart rate regulation in GIRK4 knockout mice.

K Wickman1, J Nemec, S J Gendler, D E Clapham.   

Abstract

Acetylcholine (ACh) released from the stimulated vagus nerve decreases heart rate via modulation of several types of ion channels expressed in cardiac pacemaker cells. Although the muscarinic-gated potassium channel I(KACh) has been implicated in vagally mediated heart rate regulation, questions concerning the extent of its contribution have remained unanswered. To assess the role of I(KACh) in heart rate regulation in vivo, we generated a mouse line deficient in I(KACh) by targeted disruption of the gene coding for GIRK4, one of the channel subunits. We analyzed heart rate and heart rate variability at rest and after pharmacological manipulation in unrestrained conscious mice using electrocardiogram (ECG) telemetry. We found that I(KACh) mediated approximately half of the negative chronotropic effects of vagal stimulation and adenosine on heart rate. In addition, this study indicates that I(KACh) is necessary for the fast fluctuations in heart rate responsible for beat-to-beat control of heart activity, both at rest and after vagal stimulation. Interestingly, noncholinergic systems also appear to modulate heart activity through I(KACh). Thus, I(KACh) is critical for effective heart rate regulation in mice.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9459446     DOI: 10.1016/s0896-6273(00)80438-9

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  119 in total

1.  Global structure, robustness, and modulation of neuronal models.

Authors:  M S Goldman; J Golowasch; E Marder; L F Abbott
Journal:  J Neurosci       Date:  2001-07-15       Impact factor: 6.167

2.  G-protein-gated potassium channels containing Kir3.2 and Kir3.3 subunits mediate the acute inhibitory effects of opioids on locus ceruleus neurons.

Authors:  Maria Torrecilla; Cheryl L Marker; Stephanie C Cintora; Markus Stoffel; John T Williams; Kevin Wickman
Journal:  J Neurosci       Date:  2002-06-01       Impact factor: 6.167

3.  Agonist unbinding from receptor dictates the nature of deactivation kinetics of G protein-gated K+ channels.

Authors:  Amy Benians; Joanne L Leaney; Andrew Tinker
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-28       Impact factor: 11.205

4.  Two pacemaker channels from human heart with profoundly different activation kinetics.

Authors:  A Ludwig; X Zong; J Stieber; R Hullin; F Hofmann; M Biel
Journal:  EMBO J       Date:  1999-05-04       Impact factor: 11.598

5.  Mechanism underlying bupivacaine inhibition of G protein-gated inwardly rectifying K+ channels.

Authors:  W Zhou; C Arrabit; S Choe; P A Slesinger
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-15       Impact factor: 11.205

6.  Single channel analysis of the regulation of GIRK1/GIRK4 channels by protein phosphorylation.

Authors:  Carmen Müllner; Daniel Yakubovich; Carmen W Dessauer; Dieter Platzer; Wolfgang Schreibmayer
Journal:  Biophys J       Date:  2003-02       Impact factor: 4.033

7.  The electrophysiological properties of spontaneously beating pacemaker cells isolated from mouse sinoatrial node.

Authors:  Hyun-Sung Cho; Makoto Takano; Akinori Noma
Journal:  J Physiol       Date:  2003-07-01       Impact factor: 5.182

8.  Graded contribution of the Gbeta gamma binding domains to GIRK channel activation.

Authors:  Rona Sadja; Noga Alagem; Eitan Reuveny
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-17       Impact factor: 11.205

Review 9.  Functional M3 muscarinic acetylcholine receptors in mammalian hearts.

Authors:  Zhiguo Wang; Hong Shi; Huizhen Wang
Journal:  Br J Pharmacol       Date:  2004-05-17       Impact factor: 8.739

10.  The Role of Inhibitory G Proteins and Regulators of G Protein Signaling in the in vivo Control of Heart Rate and Predisposition to Cardiac Arrhythmias.

Authors:  Richard Ang; Aaisha Opel; Andrew Tinker
Journal:  Front Physiol       Date:  2012-04-24       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.